Clinical Trial: Efficacy of 12-week continuous application lipids derived from animal at two dosage levels on scalp barrier function: a randomized, single-blind trial (Japan)

Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059262) titled 'Efficacy of 12-week continuous application lipids derived from animal at two dosage levels on scalp barrier function' on Oct. 6.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Double blind -all involved are blinded Control - No treatment

Primary Sponsor: Institute - Pharma Foods International Co.,Ltd

Condition: Condition - no Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the efficacy of 12-week application of the test sample on scalp barrier function and subjective questionnaire assessments related to scalp dryness. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Duration: one week 0.001% lipids derived from animal Solution Interventions/Control_2 - Duration: one week 0.01% lipids derived from animal solution

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1. Japanese

2. Men or women

3. Adults

4. Healthy individuals

5. Individuals who are concerned about scalp dryness in daily life Key exclusion criteria - 1. Individuals currently receiving medication or outpatient treatment for any serious medical condition 2. Individuals who are undergoing exercise or alimentary therapy under medical supervision 3. Individuals with skin or scalp conditions, including atopic dermatitis, contact dermatitis, skin hypersensitivity, or scalp redness and itchiness 4. Individuals with allergic diseases, including egg allergy 5. Individuals with extremely irregular lifestyle habits, such as diet or sleep 6. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study Target Size - 13

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 10 Month 06 Day Anticipated trial start date - 2025 Year 10 Month 06 Day Last follow-up date - 2025 Year 12 Month 26 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067760

Disclaimer: Curated by HT Syndication.